Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 15;139(2):322-33.
doi: 10.1002/ijc.30080. Epub 2016 Mar 30.

Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study

Affiliations

Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study

Matthias Schindler et al. Int J Cancer. .

Abstract

Survivors of childhood cancer have a higher mortality than the general population. We describe cause-specific long-term mortality in a population-based cohort of childhood cancer survivors. We included all children diagnosed with cancer in Switzerland (1976-2007) at age 0-14 years, who survived ≥5 years after diagnosis and followed survivors until December 31, 2012. We obtained causes of death (COD) from the Swiss mortality statistics and used data from the Swiss general population to calculate age-, calendar year-, and sex-standardized mortality ratios (SMR), and absolute excess risks (AER) for different COD, by Poisson regression. We included 3,965 survivors and 49,704 person years at risk. Of these, 246 (6.2%) died, which was 11 times higher than expected (SMR 11.0). Mortality was particularly high for diseases of the respiratory (SMR 14.8) and circulatory system (SMR 12.7), and for second cancers (SMR 11.6). The pattern of cause-specific mortality differed by primary cancer diagnosis, and changed with time since diagnosis. In the first 10 years after 5-year survival, 78.9% of excess deaths were caused by recurrence of the original cancer (AER 46.1). Twenty-five years after diagnosis, only 36.5% (AER 9.1) were caused by recurrence, 21.3% by second cancers (AER 5.3) and 33.3% by circulatory diseases (AER 8.3). Our study confirms an elevated mortality in survivors of childhood cancer for at least 30 years after diagnosis with an increased proportion of deaths caused by late toxicities of the treatment. The results underline the importance of clinical follow-up continuing years after the end of treatment for childhood cancer.

Keywords: cancer registry; cancer survivors; cardiovascular; causes of death; childhood cancer; mortality; respiratory; second primary cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cause‐specific probability of death for different causes of death in 5‐year survivors of childhood cancer diagnosed at age 0–14 years between 1976 and 2007 (cumulative mortality treating cause of death other than the one under observation as competing risks).
Figure 2
Figure 2
Cumulative mortality from all causes in 5‐year survivors of childhood cancer diagnosed at age 0–14 years according to the specific treatment area. p values form log‐rank test for trend.

References

    1. Bouchardy C, Lutz JM, Kuehni C, Purry P, Wyss N, Strippoli MP. Childhood Cancers. In: Cancer in Switzerland ‐ Situation and development from 1983 to 2007. Neucâtel: Federal Statistical Office (FSO), 2011:72–77
    1. National Center for Health Statistics. [March 14, 2016] Deaths: Final Data for 2013. Number of deaths from selected causes. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf
    1. Gatta G, Botta L, Rossi S, et al Childhood cancer survival in Europe 1999‐0000: results of EUROCARE‐0000‐a population‐based study. Lancet Oncol 2014;15:35–47. - PubMed
    1. Madanat‐Harjuoja LM, Pokhrel A, Kivivuori SM, et al Childhood cancer survival in Finland (1953‐0000): a nation‐wide population‐based study. Int J Cancer 2014;135:2129–34. - PubMed
    1. Gatta G, Capocaccia R, Stiller C, et al Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005;23:3742–51. - PubMed

Publication types